Materias dentro de su búsqueda.
Mostrando 1,621 - 1,640 Resultados de 1,900 Para Buscar '"AstraZeneca"', tiempo de consulta: 0.13s Limitar resultados
  1. 1621
    “…[Figure: see text] DISCLOSURES: Ellie Carmody, MD, MPH, AstraZeneca: Stocks/Bonds|Merck: Stocks/Bonds Lalitha Parameswaran, MD, MPH, Pfizer: Grant/Research Support Mark J. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1495. Mpox Vaccine Immunity in People Living with HIV (PLWH) During The 2022 Mpox Outbreak in New York City
  2. 1622
    “…DISCLOSURES: Ron Dagan, Professor MD, GSK: Honoraria|MedIMmune/AstraZeneca: Grant/Research Support|MSD: Advisor/Consultant|MSD: Grant/Research Support|MSD: Honoraria|Pfizer: Advisor/Consultant|Pfizer: Expert Testimony|Pfizer: Grant/Research Support|Pfizer: Honoraria|Sanofi Pasteur: Honoraria David Greenberg, Professor MD, GSK: Advisor/Consultant|GSK: Honoraria|MSD: Advisor/Consultant|MSD: Grant/Research Support|MSD: Honoraria|Pfizer: Advisor/Consultant|Pfizer: Honoraria Shalom Ben-Shimol, Dr. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2618. Four Respiratory Viruses are Involved in the Majority of Community-Acquired Alveolar Pneumonia (CAAP) Episodes in Children < 5 Years
  3. 1623
    “…Fowler, MD, MHS, Amphliphi Biosciences, Integrated Biotherapeutics; C3J, Armata, Valanbio; Akagera, Aridis, Roche, Astra Zeneca: Advisor/Consultant|Genentech, Regeneron, Deep Blue, Basilea, Janssen;: Grant/Research Support|Infectious Diseases Society of America: Honoraria|MedImmune, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius;: Grant/Research Support|Novartis, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., MedImmune, Bayer, Basilea, Affinergy, Janssen, Contrafect, Regeneron, Destiny,: Advisor/Consultant|Sepsis diagnostic: Patent pending|UpToDate: Royalties|Valanbio and ArcBio: Stock Options Joshua T. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    224. Clinical Relevance of Antibiotic Tolerance in Recurrent Gram-negative Bloodstream Infections
  4. 1624
    “…FUNDING: Cancer Research UK and AstraZeneca.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial
  5. 1625
    “…Alere, Actelion Pharma, Astellas, Optimer, Sanofi pasteur, Summit Pharma, bioMerieux, Da Volterra, Qiagen, Cerexa, Abbott, AstraZeneca, Pfizer, Durata Therapeutics, Seres Therapeutics, Valneva, Nabriva Therapeutics, Roche, The Medicines Company, Basilea P: Consultant, Consulting fee. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clostridium difficile: Investigating Transmission Patterns Between Symptomatic and Asymptomatic Patients Using Whole Genome Sequencing
  6. 1626
    “…These findings require further validation. FUNDING: AstraZeneca ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13300-018-0449-6) contains supplementary material, which is available to authorized users.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
  7. 1627
    “…Espinosa, Gilead: Grant Investigator, Grant recipient; AstraZeneca: Investigator and Speaker’s Bureau, Research grant and Speaker honorarium; Cempra: Investigator, Research grant; The Medicines Company/ Melinta Therapeutics: Investigator, Research grant; Regeneron Pharmaceuticals, Inc.: Investigator, Research grant; Merck: Investigator, Research grant; Astellas pharma Europe B.V (APEB): Investigator, Research grant; Cubist pharmaceutical: Investigator, Research grant; Rempex Pharmaceuticals, Inc.: Investigator, Research grant; Tetraphase Pharmaceuticals: Investigator, Research grant; Multiple Industry Sponsors: Investigator, Research grant.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2214. Chronic Hepatitis C: Closing the Gap Towards Eradication—Screening Young Adults vs. Baby Boomers
  8. 1628
    “…I.B.H. has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects focused on the identification and better management of anxiety and depression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Association between suicidal ideation and suicide: meta-analyses of odds ratios, sensitivity, specificity and positive predictive value
  9. 1629
    por FitzGerald, J. Mark, Tran, Trung N., Alacqua, Marianna, Altraja, Alan, Backer, Vibeke, Bjermer, Leif, Bjornsdottir, Unnur, Bourdin, Arnaud, Brusselle, Guy, Bulathsinhala, Lakmini, Busby, John, Canonica, Giorgio W., Carter, Victoria, Chaudhry, Isha, Cho, You Sook, Christoff, George, Cosio, Borja G., Costello, Richard W., Eleangovan, Neva, Gibson, Peter G., Heaney, Liam G., Heffler, Enrico, Hew, Mark, Hosseini, Naeimeh, Iwanaga, Takashi, Jackson, David J., Jones, Rupert, Koh, Mariko S., Le, Thao, Lehtimäki, Lauri, Ludviksdottir, Dora, Maitland-van der Zee, Anke H., Menzies-Gow, Andrew, Murray, Ruth B., Papadopoulos, Nikolaos G., Perez-de-Llano, Luis, Peters, Matthew, Pfeffer, Paul E., Popov, Todor A., Porsbjerg, Celeste M., Price, Chris A., Rhee, Chin K., Sadatsafavi, Mohsen, Tohda, Yuji, Wang, Eileen, Wechsler, Michael E., Zangrilli, James, Price, David B.
    Publicado 2020
    “…ISAR’s collaborators include Optimum Patient Care, the Respiratory Effectiveness Group (REG) and AstraZeneca. ISAR is overseen by the ISC, REG, the Anonymised Data Ethics & Protocol Transparency Committee and the ISAR operational committee, ensuring the conduct of ethical, clinically relevant research that brings value to all key stakeholders. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    International severe asthma registry (ISAR): protocol for a global registry
  10. 1630
    “…DISCLOSURES: Pierre Bulpa, MD, Amplyx Pharmaceuticals (Scientific Research Study Investigator) Galia Rahav, MD, AstraZeneca (Scientific Research Study Investigator) Mickaël Aoun, MD, Amplyx Pharmaceuticals (Scientific Research Study Investigator) Peter Pappas, MD, SCYNEXIS, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial
  11. 1631
    “…DISCLOSURES: Jaime Fergie, MD, AstraZeneca (Speaker’s Bureau)Sobi, Inc. (Speaker’s Bureau) Tara Gonzales, MD, Sobi, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1520. Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at the Start of RSV Season With Bronchopulmonary Dysplasia/Chronic Lung Disease of Prematurity (BPD/CLDP) Before and After the 2014 American Academy of Pediatrics (AAP) Policy
  12. 1632
    “…DISCLOSURES: Alpana Waghmare, MD, Amazon (Grant/Research Support)Amazon (Employee, Shareholder)Ansun Biopharma (Scientific Research Study Investigator)Kyorin Pharmaceuticals (Advisor or Review Panel member) Janet A. Englund, MD, AstraZeneca (Scientific Research Study Investigator)GSK group of companies (Scientific Research Study Investigator)Meissa vaccines (Consultant)Merck (Scientific Research Study Investigator)Sanofi Pasteur (Consultant) Michael Boeckh, MD PhD, AlloVir (Consultant)EvrysBio (Advisor or Review Panel member, Other Financial or Material Support, share options)Gilead (Consultant, Grant/Research Support)GSK (Consultant)Helocyte (Advisor or Review Panel member, Shareholder)Lophius (Grant/Research Support)Merck (Consultant, Grant/Research Support)SymBio (Consultant)VirBio (Consultant, Grant/Research Support)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1523. Seasonal Human Coronavirus Infections Following Allogeneic Hematopoietic Cell Transplantation: Factors Associated With Lower Respiratory Tract Infection
  13. 1633
    “…Diagnosis of COVID-19 relied on a positive RT-PCR nasopharyngeal swab, while immunization was assessed after two shots of either a mRNA (Pfizer®/Moderna®) or a viral vector (Astra Zeneca®) vaccine, using the Elecsys immunoassay (Roche®) that measures anti-SARS-CoV-2 antibodies including IgG. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    P-147: COVID-19, impact of vaccination in myeloma patients
  14. 1634
    “…Des réactions cutanées ont été observées entre 3 et 12 jours après la première dose chez 5, 1 et 2 patients qui ont respectivement reçu le vaccin Pfizer, Moderna et Oxford–AstraZeneca contre la COVID-19. Nous avons observé 2 éruptions morbilliformes, un érythème cutané diffus, une pustulose exanthématique aiguë généralisée, un érythème pigmenté fixe, une plaque œdématiée localisée, des engelures et un livedo racemosa. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Réactions cutanées rares aux vaccins contre la COVID-19 : série de cas monocentrique et revue de la littérature
  15. 1635
    “…(Consultant, Grant/Research Support) Matthew Sims, MD, PhD, Astra Zeneca (Independent Contractor)Diasorin Molecular (Independent Contractor)Epigenomics Inc (Independent Contractor)Finch (Independent Contractor)Genentech (Independent Contractor)Janssen Pharmaceuticals NV (Independent Contractor)Kinevant Sciences gmBH (Independent Contractor)Leonard-Meron Biosciences (Independent Contractor)Merck and Co (Independent Contractor)OpGen (Independent Contractor)Prenosis (Independent Contractor)Regeneron Pharmaceuticals Inc (Independent Contractor)Seres Therapeutics Inc (Independent Contractor)Shire (Independent Contractor)Summit Therapeutics (Independent Contractor)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    630. Emergence of Colistin Resistance in the OVERCOME Trial: Impact of Combination Therapy with Meropenem
  16. 1636
    “…Pannaraj, MD, MPH, Pfizer (Grant/Research Support)Sanofi-Pasteur (Advisor or Review Panel member)Seqirus (Advisor or Review Panel member) Larry Givner, MD, AstraZeneca (Advisor or Review Panel member) Kristina G. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    183. Decrease in Invasive Pneumococcal Disease in 7 United States Children’s Hospitals during the COVID-19 Pandemic
  17. 1637
    “…. * This study was supported by CDC BAA75D301-20-R-67897 DISCLOSURES: Jesse Bloom, PhD, Flagship Labs 77 (Consultant)Moderna (Consultant) Janet A. Englund, MD, AstraZeneca (Consultant, Grant/Research Support)GlaxoSmithKline (Research Grant or Support)Meissa Vaccines (Consultant)Pfizer (Research Grant or Support)Sanofi Pasteur (Consultant)Teva Pharmaceuticals (Consultant)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB9. Longitudinal antibody dynamics in children infected with SARS-CoV-2 through 6 months post-infection
  18. 1638
    “…DISCLOSURES: Lan Duong, Pharm.D., Astra Zeneca (Shareholder)Eli Lilly & Co. (Shareholder)Gilead Sciences, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    286. Infectious Complications and Antimicrobial Utilization in Hospitalized Patients with COVID-19
  19. 1639
    “…DISCLOSURES: Alpana Waghmare, MD, Allovir (Scientific Research Study Investigator)Ansun Biopharma (Scientific Research Study Investigator)Kyorin Pharmaceutical (Advisor or Review Panel member) Janet A. Englund, MD, AstraZeneca (Consultant, Grant/Research Support)GlaxoSmithKline (Research Grant or Support)Meissa Vaccines (Consultant)Pfizer (Research Grant or Support)Sanofi Pasteur (Consultant)Teva Pharmaceuticals (Consultant) Michael Boeckh, MD PhD, AlloVir (Consultant)Ansun Biopharma (Grant/Research Support)Astellas (Grant/Research Support)EvrysBio (Consultant, Other Financial or Material Support, Options to acquire equity, but have not exercised them)Gilead Sciences (Consultant, Grant/Research Support)GlaxoSmithKline (Consultant)Helocyte (Consultant, Other Financial or Material Support, Options to acquire equity, but have not exercised them)Janssen (Grant/Research Support)Kyorin (Consultant)Merck (Consultant, Grant/Research Support)Moderna (Consultant)Symbio (Consultant)Takeda (formerly known as Shire) (Consultant, Grant/Research Support)VirBio (Consultant, Grant/Research Support)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    923. Respiratory Syncytial and Parainfluenza Virus Infection Increase the Risk of Cytomegalovirus Reactivation in Allogeneic Hematopoietic Cell Transplant Recipients
  20. 1640
    “…Results will be disseminated in peer-reviewed journals and at scientific conferences. DRUG SUPPLY: AstraZeneca. PROTOCOL VERSION: CTC 0231 / TOGA 18/001 / PrE0506 3.0, 29 July 2021. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial
Herramientas de búsqueda: RSS